02367 GIANT BIOGENE
- 53.450
- +1.450+2.79%
GIANT BIOGENE News
GIANT BIOGENE: Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 30 April 2024
GIANT BIOGENE: FORM OF PROXY FOR USE AT 2023 ANNUAL GENERAL MEETING TO BE HELD ON 13 JUNE 2024
GIANT BIOGENE: NOTICE OF ANNUAL GENERAL MEETING
GIANT BIOGENE: PROPOSED RE-APPOINTMENT OF AUDITOR PROPOSED RE-ELECTION OF DIRECTORS PROPOSED GRANT OF GENERAL MANDATES TO REPURCHASE SHARES AND ISSUE SHARES PROPOSED DECLARATION AND DISTRIBUTION OF FINAL DIVIDENDS AND SPECIAL DIVIDENDS PROPOSED ADOPTION OF THE AMENDED AN
GIANT BIOGENE: 2023 Environmental, Social and Governance (ESG) Report
GIANT BIOGENE: ANNUAL REPORT 2023
GIANT BIOGENE: Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 March 2024
GIANT BIOGENE: PROPOSED ADOPTION OF THE AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION
GIANT BIOGENE: Special Dividend for the Year Ended 31 December 2023
GIANT BIOGENE: Final Dividend for the Year Ended 31 December 2023
GIANT BIOGENE: ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2023
GIANT BIOGENE: DATE OF BOARD MEETING
GIANT BIOGENE: Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 29 February 2024
GIANT BIOGENE: Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 January 2024
GIANT BIOGENE: Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 December 2023
GIANT BIOGENE: GRANT OF OPTIONS UNDER SHARE OPTION SCHEME
GIANT BIOGENE: Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 30 November 2023
GIANT BIOGENE: Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 October 2023
GIANT BIOGENE: Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 30 September 2023
GIANT BIOGENE: List of Directors and their Roles and Functions
Analysis
Price Target
No Data
